Home
Phasebio Pharmaceuticals, Inc.

十一月 2025的Phasebio Pharmaceuticals...市场份额分析

The Investor Relations website contains information about PhaseBio Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

健康 > 生物科技及制药

域phasebio.com

成立年份2002

员工51 - 200

年营收$10M - $15M

Phasebio Pharmaceuticals, Inc.

Phasebio Pharmaceuticals, Inc.（包含公司地区分支机构）

phasebio.com

查看更多网站流量和参与度信息

Phasebio Pharmaceuticals, Inc.收入截至十一月 2025为 10M - 15M

Phasebio Pharmaceuticals, Inc.主要域名产生的收入

3 年中Phasebio Pharmaceuticals, Inc.主要域名的收入

Phasebio Pharmaceuticals, Inc.主要域名的收入

phasebio.com10M - 15M

使用销售情报查看更多信息

Phasebio Pharmaceuticals, Inc.热门域名的总访问量

了解Phasebio Pharmaceuticals, Inc.市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

phasebio.com706

使用销售情报查看更多信息

Phasebio Pharmaceuticals, Inc.热门域名的平均访问时长

分析Phasebio Pharmaceuticals, Inc.参与度指标。

过去 3 个月的平均访问时长

子公司明细

phasebio.com00:00:53

使用销售情报查看更多信息

Phasebio Pharmaceuticals, Inc.热门域名的平均页面浏览量

了解Phasebio Pharmaceuticals, Inc.如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

phasebio.com2.16

使用销售情报查看更多信息

Phasebio Pharmaceuticals, Inc. 排名靠前的竞争对手（按域名）

十一月 2025的热门相似网站，按亲和力排名

clinipace.com公司名称Clinipace员工1001 - 5000总部美国, 北卡罗来纳, Morrisville年营收$200M - $500M总访问量--健康 > 生物科技及制药

Phasebio Pharmaceuticals, Inc. 采用的主要技术

这些是排名前 Phasebio Pharmaceuticals, Inc. 的顶级域名所使用的网站技术（按行业分列）

转化和分析 (8)

Google Analytics

小部件 (6)

Twemoji

付费广告 (3)

Google Adsense

内容管理系统 (3)

WordPress

更多技术

9

查看全部

Phasebio Pharmaceuticals, Inc. 的新闻与信号

借助 Similarweb 销售信号提醒，每当在目标受众之中出现新的机会或威胁时，您都会收到所识别出购买信号的每日更新。

新闻Phasebio has issues with potential breach of fiduciary duty claim.Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS).

新闻Phasebio had issues with Chapter 11 bankruptcy on Oct 31st '22.PhaseBio plans to file Chapter 11 bankruptcy and sell off its bentracimab assets under a "stalking horse: arrangement with an unnamed large pharmaceutical company, the company announced Monday.

新闻Phasebio receives financing of $40M in Series C.The center will be located near the Research Triangle Park in Cary, North Carolina where the company will, according to Novozymes, invest $36 million over the next three years and… PhaseBio Pharmaceuticals, Inc. a biopolymer-based drug manufacturer, has raised $40 million in a Series C round of funding, which includes a major share from AstraZeneca.

十一月 2025的Phasebio Pharmaceuticals...市场份额分析

Phasebio Pharmaceuticals, Inc.收入截至 十一月 2025为 10M - 15M

3 年中Phasebio Pharmaceuticals, Inc.主要域名的收入

Phasebio Pharmaceuticals, Inc.主要域名的收入

Phasebio Pharmaceuticals, Inc.热门域名的总访问量

过去 3 个月的总访问量

Phasebio Pharmaceuticals, Inc.热门域名的平均访问时长

过去 3 个月的平均访问时长

Phasebio Pharmaceuticals, Inc.热门域名的平均页面浏览量

过去 3 个月的平均页面浏览量

Phasebio Pharmaceuticals, Inc. 排名靠前的竞争对手（按域名）

Phasebio Pharmaceuticals, Inc. 采用的主要技术

转化和分析 (8)

小部件 (6)

付费广告 (3)

内容管理系统 (3)

Phasebio Pharmaceuticals, Inc. 的新闻与信号

Phasebio Pharmaceuticals, Inc.收入截至十一月 2025为 10M - 15M